Log In
Print this Print this

PXS25, PXS25/64

  Manage Alerts
Collapse Summary General Information
Company Pharmaxis Ltd.
DescriptionInhibitor of leucocyte extravasation
Molecular Target Transforming growth factor (TGF) beta 1 (TGFB1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPulmonary fibrosis
Indication DetailsTreat pulmonary fibrosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today